Navigation

TA61 Colorectal cancer - capecitabine and tegafur uracil: understanding NICE guidance

This information on the use of capecitabine and tegafur uracil for metastatic colorectal cancer is provided for people with colorectal cancer and the public, and provides an explanation of the guidance.

This page was last updated: 29 December 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.